YearStart int64 2.02k 2.02k | YearEnd int64 2.02k 2.02k | LocationAbbr stringclasses 55 values | LocationDesc stringclasses 55 values | DataSource stringclasses 14 values | Topic stringclasses 19 values | Question stringclasses 109 values | Response float64 | DataValueUnit stringclasses 8 values | DataValueType stringclasses 12 values | DataValue float64 0 2.93M ⌀ | DataValueAlt float64 0 2.93M ⌀ | DataValueFootnoteSymbol stringclasses 9 values | DataValueFootnote stringclasses 9 values | LowConfidenceLimit float64 0 1.43k ⌀ | HighConfidenceLimit float64 0 1.49k ⌀ | StratificationCategory1 stringclasses 5 values | Stratification1 stringclasses 26 values | StratificationCategory2 float64 | Stratification2 float64 | StratificationCategory3 float64 | Stratification3 float64 | Geolocation stringclasses 54 values | LocationID int64 1 78 | TopicID stringclasses 19 values | QuestionID stringclasses 109 values | ResponseID float64 | DataValueTypeID stringclasses 12 values | StratificationCategoryID1 stringclasses 5 values | StratificationID1 stringclasses 26 values | StratificationCategoryID2 float64 | StratificationID2 float64 | StratificationCategoryID3 float64 | StratificationID3 float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,020 | 2,020 | US | United States | BRFSS | Health Status | Recent activity limitation among adults | null | Number | Age-adjusted Mean | 2.9 | 2.9 | null | null | 2.8 | 2.9 | Sex | Female | null | null | null | null | null | 59 | HEA | HEA04 | null | AGEADJMEAN | SEX | SEXF | null | null | null | null |
2,015 | 2,019 | AR | Arkansas | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 9,537 | 9,537 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-92.27449074299966 34.74865012400045) | 5 | CAN | CAN07 | null | NMBR | SEX | SEXM | null | null | null | null |
2,015 | 2,019 | CA | California | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | Number | Number | 486 | 486 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-120.99999953799971 37.63864012300047) | 6 | CAN | CAN03 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,015 | 2,019 | CO | Colorado | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 2,880 | 2,880 | null | null | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-106.13361092099967 38.843840757000464) | 8 | CAN | CAN07 | null | NMBR | RACE | HIS | null | null | null | null |
2,015 | 2,019 | GA | Georgia | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | Number | Number | 519 | 519 | null | null | null | null | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-83.62758034599966 32.83968109300048) | 13 | CAN | CAN05 | null | NMBR | RACE | WHT | null | null | null | null |
2,015 | 2,019 | KS | Kansas | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 8,102 | 8,102 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-98.20078122699965 38.34774030000045) | 20 | CAN | CAN07 | null | NMBR | SEX | SEXM | null | null | null | null |
2,015 | 2,019 | ME | Maine | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 9,238 | 9,238 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-68.98503133599962 45.254228894000505) | 23 | CAN | CAN07 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,015 | 2,019 | NJ | New Jersey | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 5,587 | 5,587 | null | null | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-74.27369128799967 40.13057004800049) | 34 | CAN | CAN07 | null | NMBR | RACE | HIS | null | null | null | null |
2,015 | 2,019 | NY | New York | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 2,547 | 2,547 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-75.54397042699964 42.82700103200045) | 36 | CAN | CAN02 | null | NMBR | SEX | SEXF | null | null | null | null |
2,015 | 2,019 | OR | Oregon | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 548 | 548 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-120.15503132599969 44.56744942400047) | 41 | CAN | CAN02 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,015 | 2,019 | SD | South Dakota | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | per 100,000 | Crude Rate | 20.2 | 20.2 | null | null | 18.4 | 22.2 | Overall | Overall | null | null | null | null | POINT (-100.3735306369997 44.353130053000484) | 46 | CAN | CAN05 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,015 | 2,019 | TX | Texas | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | per 100,000 | Crude Rate | 2.9 | 2.9 | null | null | 2.8 | 3 | Sex | Female | null | null | null | null | POINT (-99.42677020599967 31.827240407000488) | 48 | CAN | CAN03 | null | CRDRATE | SEX | SEXF | null | null | null | null |
2,015 | 2,019 | US | United States | US Cancer DVT | Cancer | Invasive cancer (all sites combined) mortality among all people, underlying cause | null | Number | Number | 314,982 | 314,982 | null | null | null | null | Sex | Male | null | null | null | null | null | 59 | CAN | CAN08 | null | NMBR | SEX | SEXM | null | null | null | null |
2,015 | 2,019 | VT | Vermont | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | per 100,000 | Crude Rate | 23 | 23 | null | null | 20.7 | 25.5 | Overall | Overall | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | 50 | CAN | CAN05 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,015 | 2,019 | WV | West Virginia | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | per 100,000 | Crude Rate | 31.6 | 31.6 | null | null | 30 | 33.2 | Sex | Female | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | 54 | CAN | CAN02 | null | CRDRATE | SEX | SEXF | null | null | null | null |
2,015 | 2,019 | WI | Wisconsin | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | per 100,000 | Age-adjusted Rate | 444.6 | 444.6 | null | null | 441.4 | 447.8 | Sex | Female | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | 55 | CAN | CAN07 | null | AGEADJRATE | SEX | SEXF | null | null | null | null |
2,020 | 2,020 | ID | Idaho | NVSS | Diabetes | Diabetic ketoacidosis mortality among all people, underlying or contributing cause | null | Number | Number | 25 | 25 | null | null | null | null | Age | Age >=65 | null | null | null | null | POINT (-114.3637300419997 43.682630005000476) | 16 | DIA | DIA04 | null | NMBR | AGE | AGE65P | null | null | null | null |
2,015 | 2,019 | WY | Wyoming | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 66 | 66 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | 56 | CAN | CAN02 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | AZ | Arizona | US Cancer DVT | Cancer | Lung and bronchial cancer mortality among all people, underlying cause | null | Number | Number | 1,408 | 1,408 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | CAN | CAN04 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | CA | California | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 4,503 | 4,503 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-120.99999953799971 37.63864012300047) | 6 | CAN | CAN02 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | CA | California | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | Number | Number | 484 | 484 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-120.99999953799971 37.63864012300047) | 6 | CAN | CAN03 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | DC | District of Columbia | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | Number | Number | null | null | ~ | Data suppressed; too few respondents or cases | null | null | Sex | Male | null | null | null | null | POINT (-77.036871 38.907192) | 11 | CAN | CAN03 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | DC | District of Columbia | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 1,479 | 1,479 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-77.036871 38.907192) | 11 | CAN | CAN07 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | FL | Florida | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | per 100,000 | Age-adjusted Rate | null | null | ~ | Data suppressed; too few respondents or cases | null | null | Sex | Male | null | null | null | null | POINT (-81.92896053899966 28.932040377000476) | 12 | CAN | CAN02 | null | AGEADJRATE | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | HI | Hawaii | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 3,644 | 3,644 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-157.85774940299973 21.304850435000446) | 15 | CAN | CAN07 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | IL | Illinois | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | Number | Number | 1,231 | 1,231 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-88.99771017799969 40.48501028300046) | 17 | CAN | CAN05 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | IL | Illinois | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | per 100,000 | Crude Rate | 560.6 | 560.6 | null | null | 558 | 563.2 | Sex | Male | null | null | null | null | POINT (-88.99771017799969 40.48501028300046) | 17 | CAN | CAN07 | null | CRDRATE | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | IA | Iowa | US Cancer DVT | Cancer | Invasive cancer (all sites combined) mortality among all people, underlying cause | null | per 100,000 | Age-adjusted Rate | 185.3 | 185.3 | null | null | 182.5 | 188.1 | Sex | Male | null | null | null | null | POINT (-93.81649055599968 42.46940091300047) | 19 | CAN | CAN08 | null | AGEADJRATE | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | KS | Kansas | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | per 100,000 | Age-adjusted Rate | 19.8 | 19.8 | null | null | 18.9 | 20.8 | Overall | Overall | null | null | null | null | POINT (-98.20078122699965 38.34774030000045) | 20 | CAN | CAN02 | null | AGEADJRATE | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | KS | Kansas | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | per 100,000 | Age-adjusted Rate | 14.6 | 14.6 | null | null | 11.2 | 18.6 | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-98.20078122699965 38.34774030000045) | 20 | CAN | CAN02 | null | AGEADJRATE | RACE | HIS | null | null | null | null |
2,016 | 2,020 | ME | Maine | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 4,764 | 4,764 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-68.98503133599962 45.254228894000505) | 23 | CAN | CAN07 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | MA | Massachusetts | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | per 100,000 | Age-adjusted Rate | 428.3 | 428.3 | null | null | 425.5 | 431.1 | Sex | Female | null | null | null | null | POINT (-72.08269067499964 42.27687047000046) | 25 | CAN | CAN07 | null | AGEADJRATE | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | MN | Minnesota | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | per 100,000 | Age-adjusted Rate | 1.2 | 1.2 | null | null | 1 | 1.4 | Overall | Overall | null | null | null | null | POINT (-94.79420050299967 46.35564873600049) | 27 | CAN | CAN03 | null | AGEADJRATE | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | MS | Mississippi | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | per 100,000 | Age-adjusted Rate | 20 | 20 | null | null | 18.8 | 21.1 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-89.53803082499968 32.745510099000455) | 28 | CAN | CAN02 | null | AGEADJRATE | RACE | WHT | null | null | null | null |
2,016 | 2,020 | MS | Mississippi | US Cancer DVT | Cancer | Lung and bronchial cancer mortality among all people, underlying cause | null | Number | Number | 1,833 | 1,833 | null | null | null | null | Overall | Overall | null | null | null | null | POINT (-89.53803082499968 32.745510099000455) | 28 | CAN | CAN04 | null | NMBR | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | NE | Nebraska | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | Number | Number | 20 | 20 | null | null | null | null | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-99.36572062299967 41.6410409880005) | 31 | CAN | CAN03 | null | NMBR | RACE | WHT | null | null | null | null |
2,016 | 2,020 | NH | New Hampshire | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | per 100,000 | Crude Rate | 622.4 | 622.4 | null | null | 614.1 | 630.9 | Sex | Female | null | null | null | null | POINT (-71.50036091999965 43.65595011300047) | 33 | CAN | CAN07 | null | CRDRATE | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | NM | New Mexico | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 4,697 | 4,697 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-106.24058098499967 34.52088095200048) | 35 | CAN | CAN07 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | NC | North Carolina | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 30,211 | 30,211 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-79.15925046299964 35.466220975000454) | 37 | CAN | CAN07 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | SC | South Carolina | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | per 100,000 | Crude Rate | 22.6 | 22.6 | null | null | 21.8 | 23.5 | Overall | Overall | null | null | null | null | POINT (-81.04537120699968 33.998821303000454) | 45 | CAN | CAN05 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | SC | South Carolina | US Cancer DVT | Cancer | Prostate cancer mortality among all males, underlying cause | null | Number | Number | 558 | 558 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-81.04537120699968 33.998821303000454) | 45 | CAN | CAN05 | null | NMBR | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | SD | South Dakota | US Cancer DVT | Cancer | Invasive cancer (all sites combined) mortality among all people, underlying cause | null | Number | Number | 7 | 7 | null | null | null | null | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-100.3735306369997 44.353130053000484) | 46 | CAN | CAN08 | null | NMBR | RACE | BLK | null | null | null | null |
2,016 | 2,020 | UT | Utah | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 6 | 6 | null | null | null | null | Race/Ethnicity | Asian or Pacific Islander, non-Hispanic | null | null | null | null | POINT (-111.58713063499971 39.360700171000474) | 49 | CAN | CAN02 | null | NMBR | RACE | API | null | null | null | null |
2,016 | 2,020 | VT | Vermont | US Cancer DVT | Cancer | Lung and bronchial cancer mortality among all people, underlying cause | null | Number | Number | 158 | 158 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-72.51764079099962 43.62538123900049) | 50 | CAN | CAN04 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | WV | West Virginia | US Cancer DVT | Cancer | Breast cancer mortality among all females, underlying cause | null | Number | Number | 286 | 286 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | 54 | CAN | CAN02 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | WV | West Virginia | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | per 100,000 | Crude Rate | 697 | 697 | null | null | 689.3 | 704.8 | Sex | Male | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | 54 | CAN | CAN07 | null | CRDRATE | SEX | SEXM | null | null | null | null |
2,016 | 2,020 | WI | Wisconsin | US Cancer DVT | Cancer | Invasive cancer (all sites combined), incidence | null | Number | Number | 16,451 | 16,451 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-89.81637074199966 44.39319117400049) | 55 | CAN | CAN07 | null | NMBR | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | WY | Wyoming | US Cancer DVT | Cancer | Colon and rectum (colorectal) cancer mortality among all people, underlying cause | null | per 100,000 | Crude Rate | 15 | 15 | null | null | 13.6 | 16.4 | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | 56 | CAN | CAN01 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | WY | Wyoming | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | per 100,000 | Crude Rate | 2.1 | 2.1 | null | null | 1.4 | 3 | Overall | Overall | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | 56 | CAN | CAN03 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,016 | 2,020 | WY | Wyoming | US Cancer DVT | Cancer | Cervical cancer mortality among all females, underlying cause | null | per 100,000 | Crude Rate | 2.1 | 2.1 | null | null | 1.4 | 3 | Sex | Female | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | 56 | CAN | CAN03 | null | CRDRATE | SEX | SEXF | null | null | null | null |
2,016 | 2,020 | WY | Wyoming | US Cancer DVT | Cancer | Invasive cancer (all sites combined) mortality among all people, underlying cause | null | Number | Number | 542 | 542 | null | null | null | null | Sex | Male | null | null | null | null | POINT (-108.10983035299967 43.23554134300048) | 56 | CAN | CAN08 | null | NMBR | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | AL | Alabama | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 40.9 | 40.9 | null | null | 34.4 | 47.7 | Sex | Female | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | SLEP | SLP01 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,020 | 2,020 | KY | Kentucky | BRFSS | Immunization | Influenza vaccination among adults | null | % | Crude Prevalence | 41.6 | 41.6 | null | null | 33 | 50.7 | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-84.77497104799966 37.645970271000465) | 21 | IMM | IMM01 | null | CRDPREV | RACE | BLK | null | null | null | null |
2,018 | 2,019 | ID | Idaho | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 27.3 | 27.3 | null | null | 22.2 | 33.1 | Sex | Male | null | null | null | null | POINT (-114.3637300419997 43.682630005000476) | 16 | SLEP | SLP01 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | KS | Kansas | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 34.2 | 34.2 | null | null | 28.3 | 40.6 | Sex | Male | null | null | null | null | POINT (-98.20078122699965 38.34774030000045) | 20 | SLEP | SLP01 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | MD | Maryland | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 41.6 | 41.6 | null | null | 35.5 | 48.1 | Sex | Female | null | null | null | null | POINT (-76.60926011099963 39.29058096400047) | 24 | SLEP | SLP01 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,018 | 2,019 | MN | Minnesota | NSCH | Nutrition, Physical Activity, and Weight Status | Children and adolescents aged 6-13 years meeting aerobic physical activity guideline | null | % | Crude Prevalence | 36.4 | 36.4 | null | null | 29 | 44.6 | Sex | Male | null | null | null | null | POINT (-94.79420050299967 46.35564873600049) | 27 | NPAW | NPW07 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | MO | Missouri | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 31.7 | 31.7 | null | null | 27 | 36.7 | Age | Age 6-14 | null | null | null | null | POINT (-92.56630005299968 38.635790776000476) | 29 | SLEP | SLP01 | null | CRDPREV | AGE | AGE6_14 | null | null | null | null |
2,018 | 2,019 | MT | Montana | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 26 | 26 | null | null | 20.8 | 32 | Sex | Female | null | null | null | null | POINT (-109.42442064499971 47.06652897200047) | 30 | SLEP | SLP01 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,018 | 2,019 | NV | Nevada | NSCH | Nutrition, Physical Activity, and Weight Status | Children and adolescents aged 6-13 years meeting aerobic physical activity guideline | null | % | Crude Prevalence | 17.2 | 17.2 | null | null | 12 | 24.1 | Sex | Male | null | null | null | null | POINT (-117.07184056399967 39.493240390000494) | 32 | NPAW | NPW07 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | ND | North Dakota | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 25.5 | 25.5 | null | null | 20.3 | 31.5 | Sex | Female | null | null | null | null | POINT (-100.11842104899966 47.47531977900047) | 38 | SLEP | SLP01 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,018 | 2,019 | US | United States | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 34.4 | 34.4 | null | null | 33.5 | 35.4 | Overall | Overall | null | null | null | null | null | 59 | SLEP | SLP01 | null | CRDPREV | OVERALL | OVR | null | null | null | null |
2,018 | 2,019 | UT | Utah | NSCH | Oral Health | Receipt of evidence-based preventive dental services in the past 12 months among children and adolescents aged 1-17 years | null | % | Crude Prevalence | 62.7 | 62.7 | null | null | 56.2 | 68.8 | Age | Age 12-17 | null | null | null | null | POINT (-111.58713063499971 39.360700171000474) | 49 | ORH | ORH05 | null | CRDPREV | AGE | AGE1217 | null | null | null | null |
2,018 | 2,019 | VI | Virgin Islands | NSCH | Oral Health | Receipt of evidence-based preventive dental services in the past 12 months among children and adolescents aged 1-17 years | null | % | Crude Prevalence | null | null | * | No data available | null | null | Sex | Male | null | null | null | null | POINT (-64.896335 18.335765) | 78 | ORH | ORH05 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,018 | 2,019 | WV | West Virginia | NSCH | Sleep | Short sleep duration among children aged 4 months to 14 years | null | % | Crude Prevalence | 45.5 | 45.5 | null | null | 38.5 | 52.7 | Age | Age 4 m - 5 y | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | 54 | SLEP | SLP01 | null | CRDPREV | AGE | AGE4M5Y | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Arthritis | Arthritis among adults | null | % | Crude Prevalence | 29.9 | 29.9 | null | null | 27.9 | 32 | Sex | Male | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | ART | ART01 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Asthma | Current asthma among adults | null | % | Crude Prevalence | 8.1 | 8.1 | null | null | 6.7 | 9.7 | Sex | Male | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | AST | AST02 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Cardiovascular Disease | Taking medicine to control high blood pressure among adults with high blood pressure | null | % | Crude Prevalence | 85.2 | 85.2 | null | null | 82.8 | 87.4 | Sex | Female | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | CVD | CVD02 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AL | Alabama | NVSS | Cardiovascular Disease | Coronary heart disease mortality among all people, underlying cause | null | Number | Number | 2,003 | 2,003 | null | null | null | null | Sex | Female | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | CVD | CVD08 | null | NMBR | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Disability | Adults with any disability | null | % | Crude Prevalence | 35.1 | 35.1 | null | null | 33.3 | 36.9 | Race/Ethnicity | White, non-Hispanic | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | DIS | DIS01 | null | CRDPREV | RACE | WHT | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Mental Health | Frequent mental distress among adults | null | % | Crude Prevalence | 21 | 21 | null | null | 18.7 | 23.6 | Age | Age 18-44 | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | MEN | MEN05 | null | CRDPREV | AGE | AGE1844 | null | null | null | null |
2,019 | 2,019 | AL | Alabama | YRBSS | Sleep | Short sleep duration among high school students | null | % | Crude Prevalence | 80 | 80 | null | null | 75.4 | 84 | Grade | Grade 12 | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | SLEP | SLP02 | null | CRDPREV | GRADE | GRD12 | null | null | null | null |
2,019 | 2,019 | AL | Alabama | BRFSS | Tobacco | Quit attempts in the past year among adult current smokers | null | % | Crude Prevalence | null | null | * | No data available | null | null | Race/Ethnicity | Hawaiian or Pacific Islander, non-Hispanic | null | null | null | null | POINT (-86.63186076199969 32.84057112200048) | 1 | TOB | TOB06 | null | CRDPREV | RACE | HAPI | null | null | null | null |
2,019 | 2,019 | AK | Alaska | BRFSS | Alcohol | Binge drinking prevalence among adults | null | % | Crude Prevalence | 11.1 | 11.1 | null | null | 8.5 | 14.4 | Sex | Female | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | ALC | ALC06 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AK | Alaska | BRFSS | Asthma | Current asthma among adults | null | % | Age-adjusted Prevalence | 13.3 | 13.3 | null | null | 10.6 | 16.5 | Sex | Female | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | AST | AST02 | null | AGEADJPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AK | Alaska | NVSS | Chronic Obstructive Pulmonary Disease | Chronic obstructive pulmonary disease mortality among adults aged 45 years and older, underlying cause | null | cases per 100,000 | Crude Rate | 70 | 70 | null | null | 60 | 80 | Overall | Overall | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | COPD | COPD05 | null | CRDRATE | OVERALL | OVR | null | null | null | null |
2,019 | 2,019 | AK | Alaska | BRFSS | Disability | Adults with any disability | null | % | Age-adjusted Prevalence | 25.5 | 25.5 | null | null | 21.9 | 29.4 | Sex | Female | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | DIS | DIS01 | null | AGEADJPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AK | Alaska | BRFSS | Health Status | Frequent physical distress among adults | null | % | Crude Prevalence | 13.4 | 13.4 | null | null | 10.6 | 16.7 | Age | Age 45-64 | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | HEA | HEA03 | null | CRDPREV | AGE | AGE4564 | null | null | null | null |
2,019 | 2,019 | AK | Alaska | BRFSS | Nutrition, Physical Activity, and Weight Status | Obesity among adults | null | % | Crude Prevalence | 26.9 | 26.9 | null | null | 22.7 | 31.6 | Age | Age 18-44 | null | null | null | null | POINT (-147.72205903599973 64.84507995700051) | 2 | NPAW | NPW14 | null | CRDPREV | AGE | AGE1844 | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | BRFSS | Alcohol | Binge drinking prevalence among adults | null | % | Crude Prevalence | 20.9 | 20.9 | null | null | 18.4 | 23.6 | Age | Age 18-44 | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | ALC | ALC06 | null | CRDPREV | AGE | AGE1844 | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | BRFSS | Arthritis | Arthritis among adults | null | % | Age-adjusted Prevalence | 28.4 | 28.4 | null | null | 21.9 | 36 | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | ART | ART01 | null | AGEADJPREV | RACE | BLK | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | BRFSS | Arthritis | Received health care provider counseling for physical activity among adults with arthritis | null | % | Crude Prevalence | 61.9 | 61.9 | null | null | 50.6 | 71.9 | Age | Age 18-44 | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | ART | ART06 | null | CRDPREV | AGE | AGE1844 | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | NVSS | Asthma | Asthma mortality among all people, underlying cause | null | Number | Number | 37 | 37 | null | null | null | null | Age | Age >=65 | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | AST | AST01 | null | NMBR | AGE | AGE65P | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | BRFSS | Chronic Obstructive Pulmonary Disease | Current smoking among adults with chronic obstructive pulmonary disease | null | % | Age-adjusted Prevalence | null | null | * | No data available | null | null | Race/Ethnicity | Asian, non-Hispanic | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | COPD | COPD02 | null | AGEADJPREV | RACE | ASN | null | null | null | null |
2,020 | 2,020 | WV | West Virginia | BRFSS | Alcohol | Binge drinking frequency among adults who binge drink | null | Number | Crude Median | null | null | **** | Data suppressed; denominator < 50 or relative standard error > 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-80.71264013499967 38.66551020200046) | 54 | ALC | ALC04 | null | CRDMEDN | RACE | HIS | null | null | null | null |
2,019 | 2,019 | AZ | Arizona | YRBSS | Sleep | Short sleep duration among high school students | null | % | Crude Prevalence | 78.4 | 78.4 | null | null | 75 | 81.5 | Sex | Male | null | null | null | null | POINT (-111.76381127699972 34.865970280000454) | 4 | SLEP | SLP02 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | AR | Arkansas | BRFSS | Arthritis | Arthritis among adults | null | % | Age-adjusted Prevalence | 33.8 | 33.8 | null | null | 31.6 | 36.1 | Sex | Female | null | null | null | null | POINT (-92.27449074299966 34.74865012400045) | 5 | ART | ART01 | null | AGEADJPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | AR | Arkansas | BRFSS | Mental Health | Depression among adults | null | % | Crude Prevalence | 27.8 | 27.8 | null | null | 24.7 | 31.1 | Age | Age 18-44 | null | null | null | null | POINT (-92.27449074299966 34.74865012400045) | 5 | MEN | MEN02 | null | CRDPREV | AGE | AGE1844 | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Alcohol | Binge drinking prevalence among adults | null | % | Age-adjusted Prevalence | 20.8 | 20.8 | null | null | 18.9 | 22.9 | Sex | Male | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | ALC | ALC06 | null | AGEADJPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Arthritis | Physical inactivity among adults with arthritis | null | % | Age-adjusted Prevalence | 26.9 | 26.9 | null | null | 22.3 | 32.1 | Overall | Overall | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | ART | ART05 | null | AGEADJPREV | OVERALL | OVR | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Arthritis | Received health care provider counseling for physical activity among adults with arthritis | null | % | Age-adjusted Prevalence | 59.9 | 59.9 | null | null | 51.6 | 67.7 | Sex | Male | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | ART | ART06 | null | AGEADJPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Cardiovascular Disease | High cholesterol among adults who have been screened | null | % | Crude Prevalence | 30 | 30 | null | null | 25.9 | 34.5 | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | CVD | CVD03 | null | CRDPREV | RACE | HIS | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Cardiovascular Disease | Taking medicine for high cholesterol among adults | null | % | Crude Prevalence | 35.1 | 35.1 | null | null | 33.1 | 37.1 | Sex | Male | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | CVD | CVD04 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | NVSS | Cardiovascular Disease | Cerebrovascular disease (stroke) mortality among all people, underlying cause | null | Number | Number | 1,252 | 1,252 | null | null | null | null | Age | Age >=65 | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | CVD | CVD07 | null | NMBR | AGE | AGE65P | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Immunization | Influenza vaccination among adults 18–64 who are at increased risk | null | % | Crude Prevalence | 45.5 | 45.5 | null | null | 35.3 | 56.2 | Race/Ethnicity | Black, non-Hispanic | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | IMM | IMM02 | null | CRDPREV | RACE | BLK | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Immunization | Influenza vaccination among adults 18–64 who are at increased risk | null | % | Crude Prevalence | 47.6 | 47.6 | null | null | 42.1 | 53.1 | Sex | Male | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | IMM | IMM02 | null | CRDPREV | SEX | SEXM | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Immunization | Pneumococcal vaccination among adults aged 65 years and older | null | % | Crude Prevalence | 74.2 | 74.2 | null | null | 72.2 | 76.1 | Overall | Overall | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | IMM | IMM04 | null | CRDPREV | OVERALL | OVR | null | null | null | null |
2,019 | 2,019 | CT | Connecticut | BRFSS | Social Determinants of Health | Lack of health insurance among adults aged 18-64 years | null | % | Crude Prevalence | 9.2 | 9.2 | null | null | 7.8 | 10.9 | Sex | Female | null | null | null | null | POINT (-72.64984095199964 41.56266102000046) | 9 | SDOH | SDH09 | null | CRDPREV | SEX | SEXF | null | null | null | null |
2,019 | 2,019 | DE | Delaware | BRFSS | Arthritis | Physical inactivity among adults with arthritis | null | % | Crude Prevalence | null | null | **** | Data suppressed; denominator < 50 or relative standard error > 30% | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-75.57774116799965 39.008830667000495) | 10 | ART | ART05 | null | CRDPREV | RACE | HIS | null | null | null | null |
2,019 | 2,019 | DE | Delaware | NVSS | Asthma | Asthma mortality among all people, underlying cause | null | cases per 100,000 | Age-adjusted Rate | null | null | ~ | Data suppressed; too few respondents or cases | null | null | Race/Ethnicity | Hispanic | null | null | null | null | POINT (-75.57774116799965 39.008830667000495) | 10 | AST | AST01 | null | AGEADJRATE | RACE | HIS | null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.